The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Anticancer Activities of Surfactin and Potential Application of Nanotechnology Assisted Surfactin Delivery
Open accessAbstract
Surfactin, a cyclic lipopeptide biosurfactant produced by various strains of Bacillus genus, has been shown to induce cytotoxicity against many cancer types, such as Ehrlich ascites, breast and colon cancers, leukemia and hepatoma. Surfactin treatment can inhibit cancer progression by growth inhibition, cell cycle arrest, apoptosis, and metastasis arrest. Owing to the potent effect of surfactin on cancer cells, numerous studies have recently investigated the mechanisms that underlie its anticancer activity. The amphiphilic nature of surfactin allows its easy incorporation nano-formulations, such as polymeric nanoparticles, micelles, microemulsions, liposomes, to name a few. The use of nano-formulations offers the advantage of optimizing surfactin delivery for an improved anticancer therapy. This review focuses on the current knowledge of surfactin properties and biosynthesis; anticancer activity against different cancer models and the underlying mechanisms involved; as well as the potential application of nano-formulations for optimal surfactin delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Enhanced Permeability and Retention (EPR) Effect for Anticancer Nanomedicine Drug Targeting
Greish, K. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-609-2_3 · Cited by 841
Understanding, recognizing, and managing toxicities of targeted anticancer therapies
Dy, G. K., & Adjei, A. A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21184 · Cited by 331
Applications of a lipopeptide biosurfactant, surfactin, produced by microorganisms
Chen, W.-C., Juang, R.-S., & Wei, Y.-H. (2015) · Biochemical Engineering Journal · doi:10.1016/j.bej.2015.07.009 · Cited by 297
Pluronics and MDR reversal: an update
Alakhova, D. Y., & Kabanov, A. V. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500298q · Cited by 224
Cited by
Bioactive Secondary Metabolites from Bacillus subtilis: A Comprehensive Review
Kaspar, F., Neubauer, P., & Gimpel, M. (2019) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b00110 · Cited by 284
Gayathiri, E., Prakash, P., Karmegam, N., Varjani, S., Awasthi, M. K., & Ravindran, B. (2022) · Agronomy · doi:10.3390/agronomy12030662 · Cited by 265
Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review
Kumari, R., Sunil, D., & Ningthoujam, R. S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.041 · Cited by 263
Philippini, R. R., Martiniano, S. E., Ingle, A. P., Franco Marcelino, P. R., Silva, G. M., Barbosa, F. G., dos Santos, J. C., & da Silva, S. S. (2020) · Frontiers in Energy Research · doi:10.3389/fenrg.2020.00152 · Cited by 112
Koim-Puchowska, B., Kłosowski, G., Mikulski, D., & Menka, A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0225108 · Cited by 23
Metadata
- Authors
- Wu, Y.-S., Ngai, S.-C., Goh, B.-H., Chan, K.-G., Lee, L.-H., & Chuah, L.-H.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2017-10-26
- Volume
- 8
- Pages
- 761-761
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2766605359
- Cited by
- 210
- References
- 5
- FWCI
- 9.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anticancer Activities of Surfactin and Potential Application of Nanotechnology Assisted Surfactin Delivery. https://app.cochat.ai/papers/10.3389/fphar.2017.00761
- The paper
- Wu, Y.-S., Ngai, S.-C., Goh, B.-H., Chan, K.-G., Lee, L.-H., & Chuah, L.-H. (2017). Anticancer Activities of Surfactin and Potential Application of Nanotechnology Assisted Surfactin Delivery. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2017.00761
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.